Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
PROLIGESTONE
Intervet Ireland Limited
QG03DA90
PROLIGESTONE
100 Mg/Ml
Suspension for Injection
POM
Canine, Feline, Ferret
Proligeston
Hormone
Authorised
1987-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Delvosteron 100 mg/ml Suspension for Injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Suspension for injection. White to off-white, aqueous, sterile suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats, dogs and ferrets. ACTIVE SUBSTANCE Proligestone 100 mg PRESERVATIVES Methyl Parahydroxybenzoate 1.02 mg Propyl Parahydroxybenzoate 0.12 mg For a full list of excipients see section 6.1. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 31/10/2014_ _CRN 7019286_ _page number: 1_ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The safety of progestogens is related to their molecular structure. Proligestone has a unique molecular configuration which makes it possible to administer Delvosteron at any stage of the oestrous cycle with little risk of undesirable effects on the endometrium. Oestrus control (i) Bitches Permanent postponement of heat (repeat injections given in ‘anoestrus’/metoestrus induced by the previous administration of Delvosteron). Temporary postponement of heat (a single injection given in anoestrus). Suppression of heat (a single injection given at the beginning of pro-oestrus). (ii) Queens Permanent postponement of calling (repeat injections given in ‘anoestrus’/di-oestrus induced by the previous administration of Delvosteron). Temporary postponement of calling (a single injection given during di-oestrus or anoestrus). Suppression of calling (a single injection given at the onset of calling). (iii) Ferrets To prevent the problems, such as vaginal and uterine infection and bone marrow depression associated with prolonged oestrus and persistently high oestrogen levels. False Lue koko asiakirja